在患有Helicobacter pylori胃炎的患者中,冠状血管变化
1Department of Ophthalmology, KTO Karatay University Medicana Konya Hospital, Konya, Turkiye.
概括
在患者中,Helicobacter pylori (H. pylori) 胃炎并没有显著改变亚管胆道厚度 (SFCT) 或胆道血管指数 (CVI). 与健康对照人群相比,这些眼部测量在活跃的H. pylori感染期间保持稳定.
科学领域:
- 眼科医生 眼科 眼科
- 胃肠病学 胃肠病学
- 医学研究 医学研究
背景情况:
- 杆菌 (H. pylori) 感染会导致慢性胃炎和炎症.
- 对于H. pylori胃炎对眼睛微血管结构的影响,特别是胸膜厚度和血管性,尚不清楚.
研究的目的:
- 为了研究活跃的H. pylori感染和亚管胆道厚度 (SFCT) 之间的关联.
- 在患有H. pylori胃炎的患者中评估胆道血管指数 (CVI).
主要方法:
- 一项前性研究,将76名H. pylori阳性患者与76名年龄和性别匹配的对照患者进行比较.
- 通过增强的深度成像光学连贯性断层扫描 (EDI-OCT) 测量下状体厚度 (SFCT).
- 冠状血管指数 (CVI) 是使用EDI-OCT扫描图像二元化计算的.
主要成果:
- 在 H. pylori 阳性患者 (359.14 ± 24.23 μm) 和对照组 (353.62 ± 12.78 μm) 之间的平均 SFCT 没有统计学上显著的差异.
- 在H. pylori组 (0.63) 和对照组 (0.62) 之间,CVI没有显著差异.
结论:
- 活跃的H. pylori感染不会导致SFCT的显著变化.
- 活跃的H. pylori胃炎仍然不会影响CVI,这表明感染期间对胆道血管无实质性影响.
更多相关视频
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
15.0K
11:48Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
Published on: May 7, 2018
10.3K
相关概念视频
01:17Gastritis-II: Pathophysiology
185
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
185
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
69
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
69
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
490
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
490
01:30Peptic Ulcer Disease I: Introduction
105
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
105
01:23Gastritis III: Clinical Manifestations and Management
102
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
102
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
322
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
322